ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,593, issued on Jan. 13, was assigned to Alivexis Inc. (Tokyo) and Astellas Pharma Inc. (Tokyo).
"Azacycloalkyl carbonyl cyclic amine compound" was invented by Takafumi Shimizu (Tokyo), Yoh Terada (Tokyo), Takeo Urakami (Tokyo), William Sinko (Delaware, Calif.), Jun Maeda (Tokyo), Tsubasa Watanabe (Tokyo) and Hiroaki Yamagishi (Tokyo).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is an azacycloalkylcarbonyl cyclic amine compound which is useful as an active ingredient in a pharmaceutical composition for a treatment of a neutrophil associated inflammatory disease. The azacycloalkylcarbonyl cyclic amine compound of the present invention is a c...